Drug General Information
Drug ID
D0E7MA
Former ID
DIB012683
Drug Name
ATG002
Indication Diabetic foot ulcer [ICD9: 707; ICD10:L88-L89] Phase 1/2 [521825]
Company
CoMentis
Target and Pathway
Target(s) Nicotinic acetylcholine receptor Target Info Agonist [551536]
References
Ref 521825ClinicalTrials.gov (NCT00316537) Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers. U.S. National Institutes of Health.
Ref 551536Athenagen Advances Angiogenesis Drug to Clinical Testing. Athenagen. JUNE 21, 2006.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.